Matches in Wikidata for { <http://www.wikidata.org/entity/Q72682030> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q72682030 description "article scientifique publié en 1994" @default.
- Q72682030 description "artículu científicu espublizáu en xunu de 1994" @default.
- Q72682030 description "im Juni 1994 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72682030 description "scientific article published on 01 June 1994" @default.
- Q72682030 description "wetenschappelijk artikel" @default.
- Q72682030 description "наукова стаття, опублікована в червні 1994" @default.
- Q72682030 name "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 name "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 type Item @default.
- Q72682030 label "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 label "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 prefLabel "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 prefLabel "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 P1433 Q72682030-C3DE3107-7FDC-466F-9664-7B75D0CCB737 @default.
- Q72682030 P1476 Q72682030-CA917DE9-B989-494B-A73F-71296E58979A @default.
- Q72682030 P2093 Q72682030-54CCB1CB-D7CB-4FB1-B54C-0FCD88DAD25D @default.
- Q72682030 P2093 Q72682030-63CE69AF-A880-48A2-A55C-618993A841CF @default.
- Q72682030 P2093 Q72682030-67A050B9-5024-4DD5-8377-C65FDC3591B7 @default.
- Q72682030 P2093 Q72682030-98F27AE9-83C5-41EC-93BC-DCBB01A5503F @default.
- Q72682030 P2093 Q72682030-A35FED0F-9D20-46C4-B177-ED07B5F58E10 @default.
- Q72682030 P2093 Q72682030-A52FC0A0-F015-4617-A1E2-D95B8DC1A5BF @default.
- Q72682030 P304 Q72682030-495D196D-C42E-4790-8909-1888D7AA21F3 @default.
- Q72682030 P31 Q72682030-DDFC36CF-4E8B-4C79-BB26-BBD615399EF8 @default.
- Q72682030 P356 Q72682030-598ED05A-6261-4195-AD53-695FEBAE801E @default.
- Q72682030 P407 Q72682030-9E84A497-B18B-411E-A3C1-C15088CFFA9B @default.
- Q72682030 P433 Q72682030-423B204B-B5BF-46FC-AD5D-D226D7BD7B43 @default.
- Q72682030 P478 Q72682030-476FBE00-4883-490A-9076-47FE74D3CCCB @default.
- Q72682030 P50 Q72682030-61DFDAEA-B7F0-4FC4-AEEE-67AD4E5E2205 @default.
- Q72682030 P577 Q72682030-7E271B5D-6A84-419A-AF70-3D118AD03620 @default.
- Q72682030 P698 Q72682030-8B820C4C-3D34-4AC5-8A7B-C7B0CE92E503 @default.
- Q72682030 P921 Q72682030-50A0E848-73AA-4095-AA01-A6822E815AF4 @default.
- Q72682030 P921 Q72682030-92E13990-663C-4CEA-BBBB-C126B6885CA7 @default.
- Q72682030 P921 Q72682030-980EE0B6-47CC-4257-A55D-F875152BB476 @default.
- Q72682030 P356 0304-3835(94)90194-5 @default.
- Q72682030 P698 7912163 @default.
- Q72682030 P1433 Q326372 @default.
- Q72682030 P1476 "ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer" @default.
- Q72682030 P2093 "A Borg" @default.
- Q72682030 P2093 "B Baldetorp" @default.
- Q72682030 P2093 "D Killander" @default.
- Q72682030 P2093 "H Sigurdsson" @default.
- Q72682030 P2093 "M Fernö" @default.
- Q72682030 P2093 "S Rydén" @default.
- Q72682030 P304 "137-144" @default.
- Q72682030 P31 Q13442814 @default.
- Q72682030 P356 "10.1016/0304-3835(94)90194-5" @default.
- Q72682030 P407 Q1860 @default.
- Q72682030 P433 "2" @default.
- Q72682030 P478 "81" @default.
- Q72682030 P50 Q59659715 @default.
- Q72682030 P577 "1994-06-01T00:00:00Z" @default.
- Q72682030 P698 "7912163" @default.
- Q72682030 P921 Q128581 @default.
- Q72682030 P921 Q412178 @default.
- Q72682030 P921 Q415271 @default.